Your browser doesn't support javascript.
loading
Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
Baeten, Jared M; Lingappa, Jairam; Beck, Ingrid; Frenkel, Lisa M; Pepper, Gregory; Celum, Connie; Wald, Anna; Fife, Kenneth H; Were, Edwin; Mugo, Nelly; Sanchez, Jorge; Essex, Myron; Makhema, Joseph; Kiarie, James; Farquhar, Carey; Corey, Lawrence.
Affiliation
  • Baeten JM; Department of Global Health, University of Washington, Seattle, Washington, USA.
J Infect Dis ; 203(1): 117-21, 2011 Jan 01.
Article in En | MEDLINE | ID: mdl-21148504
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Valine / Acyclovir / Herpes Genitalis / HIV Infections / HIV-1 / Drug Resistance, Viral Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa / America do norte / America do sul / Peru Language: En Journal: J Infect Dis Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Valine / Acyclovir / Herpes Genitalis / HIV Infections / HIV-1 / Drug Resistance, Viral Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa / America do norte / America do sul / Peru Language: En Journal: J Infect Dis Year: 2011 Document type: Article Affiliation country: Country of publication: